MDRX
Income statement / Annual
Last year (2022), Allscripts Healthcare Solutions, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2022, Allscripts Healthcare Solutions, Inc.'s net income was $0.00.
See Allscripts Healthcare Solutions, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$0.00
|
$1.50 B
|
$1.50 B
|
$1.77 B
|
$1.75 B
|
$1.81 B
|
$1.55 B
|
$1.39 B
|
$1.38 B
|
$1.37 B
|
| Cost of Revenue |
$0.00 |
$883.40 M |
$937.01 M |
$1.06 B |
$1.03 B |
$1.02 B |
$878.90 M |
$805.80 M |
$831.90 M |
$838.60 M |
| Gross Profit |
$0.00 |
$619.60 M |
$565.70 M |
$713.60 M |
$724.60 M |
$782.10 M |
$671.00 M |
$580.60 M |
$546.00 M |
$534.50 M |
| Gross Profit Ratio |
0 |
0.41 |
0.38 |
0.4 |
0.41 |
0.43 |
0.43 |
0.42 |
0.4 |
0.39 |
| Research and Development
Expenses |
$0.00
|
$193.70 M
|
$206.06 M
|
$254.50 M
|
$268.40 M
|
$220.20 M
|
$187.90 M
|
$184.80 M
|
$192.80 M
|
$199.80 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$0.00
|
$313.80 M
|
$389.94 M
|
$419.80 M
|
$451.00 M
|
$486.30 M
|
$392.80 M
|
$339.20 M
|
$358.70 M
|
$419.60 M
|
| Other Expenses |
$0.00 |
$23.10 M |
$25.60 M |
$27.20 M |
$26.60 M |
$33.70 M |
$1.09 M |
$2.18 M |
$400,000.00 |
$7.30 M |
| Operating Expenses |
$0.00 |
$530.60 M |
$621.61 M |
$701.50 M |
$746.00 M |
$740.20 M |
$606.50 M |
$547.20 M |
$582.80 M |
$650.60 M |
| Cost And Expenses |
$0.00 |
$1.41 B |
$1.56 B |
$1.76 B |
$1.77 B |
$1.76 B |
$1.49 B |
$1.35 B |
$1.41 B |
$1.49 B |
| Interest Income |
$0.00 |
$1.10 M |
$34,104.00 |
$43,172.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$13.20 M |
$34.10 M |
$43.20 M |
$50.90 M |
$87.50 M |
$63.00 M |
$30.00 M |
$29.30 M |
$28.00 M |
| Depreciation &
Amortization |
$228,485.00
|
$192.78 M
|
$236.59 M
|
$250.61 M
|
$192.35 M
|
$157.33 M
|
$172.39 M
|
$161.00 M
|
$174.30 M
|
$178.80 M
|
| EBITDA |
$0.00
|
$279.81 M
|
$77.06 M
|
-$24.46 M
|
$173.07 M
|
$41.92 M
|
$240.38 M
|
$199.95 M
|
$135.44 M
|
$54.62 M
|
| EBITDA Ratio |
0 |
0.24 |
0.12 |
0.06 |
0.1 |
0.14 |
0.15 |
0.14 |
0.1 |
0.05 |
| Operating Income Ratio
|
0
|
0.12
|
-0.03
|
-0.07
|
-0.01
|
0.02
|
0.04
|
0.02
|
-0.03
|
-0.09
|
| Total Other
Income/Expenses Net |
$0.00
|
$72.86 M
|
-$93.40 M
|
-$155.65 M
|
$106.19 M
|
-$231.94 M
|
-$36.15 M
|
-$31.31 M
|
-$28.93 M
|
-$20.75 M
|
| Income Before Tax |
$0.00 |
$161.80 M |
-$149.31 M |
-$206.50 M |
$13.10 M |
-$209.60 M |
-$14.80 M |
$600,000.00 |
-$68.10 M |
-$148.30 M |
| Income Before Tax Ratio
|
0
|
0.11
|
-0.1
|
-0.12
|
0.01
|
-0.12
|
-0.01
|
0
|
-0.05
|
-0.11
|
| Income Tax Expense |
$0.00 |
$27.90 M |
-$16.69 M |
-$23.90 M |
$400,000.00 |
-$50.70 M |
-$17.80 M |
$2.60 M |
-$1.60 M |
-$44.30 M |
| Net Income |
$0.00 |
$134.44 M |
-$132.62 M |
-$182.60 M |
$363.70 M |
-$196.50 M |
-$25.70 M |
-$2.20 M |
-$66.50 M |
-$104.00 M |
| Net Income Ratio |
0 |
0.09 |
-0.09 |
-0.1 |
0.21 |
-0.11 |
-0.02 |
-0 |
-0.05 |
-0.08 |
| EPS |
0 |
1.03 |
-0.83 |
-1.1 |
2.07 |
-1.09 |
-0.14 |
-0.0119 |
-0.37 |
-0.59 |
| EPS Diluted |
0 |
0.96 |
-0.83 |
-1.1 |
2.04 |
-1.09 |
-0.14 |
-0.0119 |
-0.37 |
-0.59 |
| Weighted Average Shares
Out |
$128.90 M
|
$130.14 M
|
$159.28 M
|
$166.31 M
|
$176.00 M
|
$180.80 M
|
$186.19 M
|
$185.08 M
|
$179.80 M
|
$177.00 M
|
| Weighted Average Shares
Out Diluted |
$128.90 M
|
$138.66 M
|
$159.28 M
|
$166.31 M
|
$178.50 M
|
$180.80 M
|
$186.20 M
|
$185.10 M
|
$179.80 M
|
$177.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
